Tsukamoto Jessica Sayuri, Belotto de Oliveira Marcos, Peixoto Renata D'alpino
Department of Medical Oncology, Hospital São José, São Paulo, Brazil.
Department of Surgical Oncology, Hospital São José, São Paulo, Brazil.
Case Rep Oncol. 2016 Feb 4;9(1):89-94. doi: 10.1159/000443827. eCollection 2016 Jan-Apr.
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal (IP) chemotherapy (HIPEC) is believed to improve outcomes in well-selected patients with peritoneal carcinomatosis. However, morbidity and mortality rates associated with this procedure are substantial. Here, we describe the case of a previously healthy young man who underwent CRS with hyperthermic IP oxaliplatin and developed one episode of tonic-clonic seizure on the second postoperative day.
细胞减灭术(CRS)联合腹腔内热灌注化疗(HIPEC)被认为可改善经严格筛选的腹膜癌患者的预后。然而,该手术相关的发病率和死亡率相当高。在此,我们描述一例既往健康的年轻男性病例,其接受了腹腔内热灌注奥沙利铂的细胞减灭术,并在术后第二天发生了一次强直 - 阵挛性癫痫发作。